Important information about Comprehensive Colposcopy Online
- All work is due by the course end date with no exceptions.
The nature of our system does not allow for extensions. All lectures are on-demand so you may view the lectures at your own pace. Note, however, the course end date. All lectures must be viewed, CME claimed, and materials downloaded by the course end date. We plan to offer (4) cohorts per year. Sign up for timeframe that is right for your schedule.
- This material is didactic.
There is no hands-on component.
Is this educational activity right for me?
This evidence-based course is designed for the beginning/intermediate colposcopist. It will also benefit clinicians needing updated information about the Cervical Cancer Screening Guidelines, the ASCCP Consensus Guidelines for Management of Women with Abnormal Cervical Cancer Screening Tests and Cancer Precursors, and new concepts about HPV screening and triage, treatment methods, and HPV epidemiology. This course is designed to improve competencies in medical knowledge, practice-based learning, patient outcomes, and/or systems-based practice. The participant should be a licensed physician or advanced practice clinician with an advanced clinical degree from an accredited institution and who makes gynecologic diagnosis and management decisions.
Educational Objectives
Upon completion of this educational activity, participants should be able to:
- Describe the anatomy, cytology, histology, and colposcopic findings of the normal and abnormal cervix, vagina, and vulva
- Integrate into practice the documentation of an appropriate history including risk factors for lower genital tract neoplasia
- Define the pathophysiology of lower genital tract neoplasia, including the role of oncogenic HPV in preinvasive and invasive diseases of the cervix, vagina, and vulva
- Define the Bethesda System of cervicovaginal terminology
- Apply new standards for cervical cancer screening, including HPV testing
- Describe the prevention of cervical neoplasia and genital warts using prophylactic HPV vaccines
- Discuss the challenges of colposcopy and management of cervical neoplasia for selected patient populations such as adolescents, women infected with HIV, underserved women, and pregnant women
- Perform appropriate cytologic sampling, colposcopic evaluation, and biopsies (including endocervical sampling), and become familiar with instrumentation and necessary supplies
- Apply into practice as needed the recognition of diagnostic characteristics of cervical abnormalities (low-grade and high-grade cervical lesions as well as adenocarcinoma in-situ and cervical cancer) on cytologic, colposcopic, and histologic exam
- Interpret and correlate cytologic, colposcopic, and histologic results
- Formulate a plan of care for the management of women with Pap test abnormalities according to the most recent ASCCP Consensus Guidelines, the ASCUS/LSIL Triage Study (ALTS), and other evidence-based guidelines
- Describe, but not perform, treatment options to include cryosurgery and electrosurgical loop excision procedure (LEEP) of the cervix
- Diagnose and manage vulvar and vaginal neoplasia
- Provide appropriate patient education and support
After successfully completing the course, participants are expected to partake in a hands-on mentored performance training as required for credentialing in new procedures by their home institutions, as this course alone will not prepare participants for independent practice.
Check back here on the course start date for a link to enter the course.
CME Info
Comprehensive Colposcopy
Is this educational activity right for me?
This evidence-based course is designed for the beginning/intermediate colposcopist. It will also benefit clinicians needing updated information about the newly published Updated Cervical Cancer Screening Guidelines, the Updated National Consensus Guidelines for Management of Women with Abnormal Cervical Cancer Screening Tests and Cancer Precursors, and new concepts about HPV screening and triage, treatment methods, and HPV epidemiology. This course is designed to improve competencies in medical knowledge, practice-based learning, patient outcomes, and/or systems-based practice. The participant should be a licensed physician or advanced practice clinician with an advanced clinical degree from an accredited institution and who makes gynecologic diagnosis and management decisions.
Educational Objectives
Upon completion of this educational activity, participants should be able to:
- Describe the anatomy, cytology, histology, and colposcopic findings of the normal and abnormal cervix, vagina, and vulva
- Integrate into practice the documentation of an appropriate history including risk factors for lower genital tract neoplasia
- Define the pathophysiology of lower genital tract neoplasia, including the role of oncogenic HPV in preinvasive and invasive diseases of the cervix, vagina, and vulva
- Define the Bethesda System of cervicovaginal terminology
- Apply new standards for cervical cancer screening, including HPV testing
- Describe the prevention of cervical neoplasia and genital warts using prophylactic HPV vaccines
- Discuss the challenges of colposcopy and management of cervical neoplasia for selected patient populations such as adolescents, women infected with HIV, underserved women, and pregnant women
- Perform appropriate cytologic sampling, colposcopic evaluation, and biopsies (including endocervical sampling), and become familiar with instrumentation and necessary supplies
- Apply into practice as needed the recognition of diagnostic characteristics of cervical abnormalities (low-grade and high-grade cervical lesions as well as adenocarcinoma in-situ and cervical cancer) on cytologic, colposcopic, and histologic exam
- Interpret and correlate cytologic, colposcopic, and histologic results
- Formulate a plan of care for the management of women with Pap test abnormalities according to the most recent ASCCP Consensus Guidelines, the ASCUS/LSIL Triage Study (ALTS), and other evidence-based guidelines
- Describe, but not perform, treatment options to include cryosurgery and electrosurgical loop excision procedure (LEEP) of the cervix
- Diagnose and manage vulvar and vaginal neoplasia
- Provide appropriate patient education and support
Continuing Medical Education (CME)
ACCME Accreditation Statement
ASCCP is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide medical education for physicians.
Credit Designation Statement
ASCCP designates this live activity for a maximum of 20 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures
All those who have an opportunity to control or influence content (Faculty, Program Directors, Reviewers, Staff, etc), are required to complete a disclosure form based on the following instructions:
ASCCP members and the general public place great trust in the work of the Society. Real or perceived undisclosed conflicts of interest may jeopardize that trust and ASCCP’s effectiveness. Conflicts of interest also may affect the objectivity of decisions that ASCCP officers and volunteers make. To minimize the potential impact of possible conflicts of interest, the Board of Directors has determined that all participants in ASCCP activities must report all real or potential conflicts prior to the activity being developed and delivered to the learners.
Additionally, the ACCME Standards for Integrity and Independence require that we disqualify individuals who refuse to provide this information from involvement in the planning and implementation of accredited continuing education.
Please disclose all financial relationships that you have had in the past 24 months with ineligible companies (see definition below). For each financial relationship, enter the name of the ineligible company and the nature of the financial relationship(s). There is no minimum financial threshold; we ask that you disclose all financial relationships, regardless of the amount, with ineligible companies. You should disclose all financial relationships regardless of the potential relevance of each relationship to the education.
An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. For specific examples of ineligible companies visit accme.org/standards.
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to ASCCP any financial relationship(s) that have occurred within the prior 24 months with any ineligible companies. Financial relationships are defined as remuneration in any amount from ineligible companies in the form of grants, research support, consulting fees, salary, ownership interest (eg, stocks, stock options, or ownership interest excluding diversified mutual funds), honoraria or other payments for participation in speakers’ bureaus, advisory boards, or boards of directors, or other financial benefits. The intent of this disclosure is not to prevent individuals with financial relationships from planning or delivering content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion. ASCCP has reviewed all disclosures and mitigated all relevant financial relationships that have been identified.
The following person(s) disclosed financial relationships:
- Anna-Barbara Moscicki, MD – Editor – Merck (Advisory Board)
The following person(s) disclosed no financial relationships:
- Allison Asante, PA-C – Content Reviewer
- Patty Cason, MS, FNP-BC - Faculty
- Christine Conageski, MD – Content Reviewer
- Michael A. Gold, MD – Program Director, Faculty, Editor
- Hope Haefner, MD – Faculty
- Xuezhi (Daniel) Jiang, MD – Content Reviewer
- Herschel Lawson, MD – Faculty
- Wendy Likes , PhD – Content Reviewer
- Jenna Marcus, MD – Editor
- E.J. Mayeaux, Jr, MD – Program Director, Faculty, Editor
- Rebecca Perkins, MD, MSc – Editor
- Colleen Stockdale, MD, MS – Program Director, Faculty, Editor
- Alan G. Waxman, MD, MPH – Faculty
- Amy Wiser, MD – Faculty
- Kerry Curtis – Staff
- Robert Pulley – Staff
- Joe Pymm – Staff
- Liesl Robinson - Staff
Program Directors
Michael Gold, MD
Associate Professor & Director, Division of Gynecology Oncology
University of Oklahoma School of Community Medicine
Department of Obstetrics & Gynecology
Tulsa, OK
E.J. Mayeaux, Jr., MD
Professor of Family Medicine
Associate Vice Chancellor for Clinical Affairs
Senior Dean for Population Health and Primary Care
LSU Health Sciences Center
Colleen K. Stockdale, MD, MS
Clinical Professor of Obstetrics and Gynecology
University of Iowa
Carver College of Medicine
Faculty
Patty Cason, MS, FNP-BC
Envision Sexual and Reproductive Health
Los Angeles, California
Michael Gold, MD
Associate Professor & Director, Division of Gynecology Oncology
University of Oklahoma School of Community Medicine
Department of Obstetrics & Gynecology
Tulsa, OK
Hope Haefner, MD
Professor
Michigan Medicine
Department of Obstetrics and Gynecology
Ann Arbor, MI
Herschel W. Lawson, MD
Adjunct Professor
Emory University School of Medicine
Department of Gynecology and Obstetrics
Atlanta, Georgia
E.J. Mayeaux, Jr., MD
Professor of Family Medicine
Associate Vice Chancellor for Clinical Affairs
Senior Dean for Population Health and Primary Care
LSU Health Sciences Center
Colleen K. Stockdale, MD, MS
Clinical Professor of Obstetrics and Gynecology
University of Iowa
Carver College of Medicine
Alan G. Waxman, MD, MPH
University of New Mexico School of Medicine
Department of Obstetrics and Gynecology
Albuquerque, New Mexico
Amy Wiser, MD
Assistant Professor
Oregon Health & Science University
Department of Family Medicine
Portland, OR
Not an ASCCP Member? Join now to get discounted registration.
Important information about Comprehensive Colposcopy Online.
- We plan to offer (4) cohorts per year. Sign up for timeframe that is right for your schedule.
- All work is due by the course end date with no exceptions.
The nature of our system does not allow for extensions. All lectures are on-demand so you may view the lectures at your own pace. Note, however, the course end date. All lectures must be viewed, CME claimed, and materials downloaded by the course end date.
- This material is didactic.
There is no hands-on component.
| Registration Type |
|
Regular |
| ASCCP Physician Member |
|
$895.00 |
| Physician Non-Member |
|
$1,195.00 |
| ASCCP Physician Assistant, Nurse/Nurse Practitioner/Midwife, Researcher Member |
|
$795.00 |
| Physician Assistant, Nurse/Nurse Practitioner/Midwife, Researcher Non-Member |
|
$1,045.00 |
| ASCCP Trainee |
|
$395.00 |
| Trainee Non-Member* |
|
$495.00 |
*Trainee Non-Members must submit proof that they are currently enrolled in a training program. Acceptable documents are a letter from your Department Chair or a Student ID.
Cancellation Policy: Written cancellation must be received at least 30 days prior to the start of the course. Any notice received by this time will be refunded, less a $100.00 administrative fee. No refunds will be made after this time.
Registration is non-transferable.
Section 1
01. The Normal Cervix: Cytology, Colposcopy, and Histology
02. Epidemiology of HPV and Cervical Cancer
03. Performing Cervical Cytology Tests
04. Cervical Cancer Screening New Approaches
05. The Evolution of Lower Genital Tract Terminology
06. Colposcopy: Equipment and Supplies
07. Colposcopy: The Procedure
08. HPV Vaccines
08.1 Gallery of Images
08.2 Common Lower Genital Tract Pathology Diagnosis
Section 2
09. Colposcopy of the Abnormal Transformation Zone
10. ASC-US/LSIL/CIN1: Cytology, Colposcopy, and Histology with Case Studies and ASCCP 2019 Management Guidelines
11. HSIL/CIN2, 3: Cytology, Colposcopy, and Histology with Case Studies and ASCCP 2019 Management Guidelines
12. Assessment of Cervical Lesions: Determining Where to Biopsy
13. Establishing U.S. Standards for Colpo Terminology and Practice
13.1. Breakout A: Interactive Case Discussion
13.2. Selecting Where to Biopsy
13.3. Breakout C: Condyloma, LSIL, HSIL and Cancer
Section 3
14. Warning Signs of Cervical Cancer
15. Glandular Lesions: Cytology, Colposcopy, and Histology with Case Studies and ASCCP 2019 Management Guidelines
16. Cervical Treatment: Indications, Ablative and Excisional Techniques and Outcomes
17. Adolescents and Young Women: A Unique Population
18. Cervical Cancer Risk and Prevention
19. Colposcopy in Pregnancy
ASCCP Risk Based Management Consensus Guidelines
Section 4
20. Management of Pre-Malignant and Malignant Diseases of the Vagina
21. Benign Conditions of the Vulva
22. Management of Neoplastic Diseases of the Vulva VIN and Vulvar Cancer
Additional Material - Severe Itch Scratch Itch Cycle Tips
Additional Material - Vulvar Unknowns
23. Case Studies Using the ASCCP 2019 Consensus Guidelines
24. Putting It All Together
Published on:
08/08/2023
Last Revised on:
06/07/2024